REVB REVELATION BIOSCIENCES, INC.
Nasdaq · SEC CIK 1810560 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 46 since 2021-09-23, latest 2026-08-18 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Zygmont Chester Stanley III | CFO | — | — |
| Rolke James | CEO, Dir | — | — |
| CARVER JENNIFER | Dir | — | — |
| Chawla Lakhmir S | Dir | — | — |
| ROPER JESS | Dir | — | — |
Transactions 43
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 17:00 | 2026-08-17 | REVB | Rolke James | CEO, Dir | A - Grant | $0.00 | +208.1K | 422.8K | +97% | $0 | |
| 2026-08-18 17:00 | 2026-08-17 | REVB | Chawla Lakhmir S | Dir | A - Grant | $0.00 | +32.0K | 44.2K | +263% | $0 | |
| 2026-08-18 17:00 | 2026-08-17 | REVB | Zygmont Chester Stanley III | CFO | A - Grant | $0.00 | +208.1K | 208.1K | New | $0 | |
| 2026-08-18 17:00 | 2026-08-17 | REVB | Zygmont Chester Stanley III | CFO | G - Gift | $0.00 | -208.1K | 0 | -100% | $0 | |
| I | 2026-08-18 17:00 | 2026-08-17 | REVB | Zygmont Chester Stanley III | CFO | G - Gift | $0.00 | +208.1K | 300.1K | +226% | $0 |
| 2026-08-18 17:00 | 2026-08-17 | REVB | ROPER JESS | Dir | A - Grant | $0.00 | +32.0K | 44.8K | +250% | $0 | |
| 2026-08-18 17:00 | 2026-08-17 | REVB | CARVER JENNIFER | Dir | A - Grant | $0.00 | +32.0K | 44.8K | +251% | $0 | |
| 2026-05-01 17:32 | 2026-04-30 | REVB | Rolke James | CEO, Dir | F - Tax | $1.13 | -10.1K | 214.7K | -4% | -$11.4K | |
| I | 2026-05-01 17:31 | 2026-04-30 | REVB | Zygmont Chester Stanley III | CFO | F - Tax | $1.10 | -13.3K | 92.1K | -13% | -$14.6K |
| I | 2026-02-05 | 2026-02-04 | REVB | Zygmont Chester Stanley III | CFO | F - Tax | $1.65 | -13.1K | 105.3K | -11% | -$21.6K |
| 2026-02-05 | 2026-02-03 | REVB | Rolke James | CEO, Dir | F - Tax | $1.86 | -8,521 | 224.9K | -4% | -$15.8K | |
| 2026-02-05 | 2026-02-03 | REVB | CARVER JENNIFER | Dir | F - Tax | $1.87 | -1,661 | 12.8K | -12% | -$3,106 | |
| 2026-02-05 | 2026-02-03 | REVB | Chawla Lakhmir S | Dir | F - Tax | $1.85 | -2,261 | 12.2K | -16% | -$4,183 | |
| 2026-02-05 | 2026-02-03 | REVB | ROPER JESS | Dir | F - Tax | $1.85 | -1,591 | 12.8K | -11% | -$2,943 | |
| 2026-01-12 | 2026-01-08 | REVB | ROPER JESS | Dir | A - Grant | $0.9 | +42.0K | 57.7K | +268% | +$37.8K | |
| I | 2026-01-12 | 2026-01-08 | REVB | Zygmont Chester Stanley III | CFO | A - Grant | $0.9 | +78.1K | 473.8K | +20% | +$70.3K |
| 2026-01-12 | 2026-01-08 | REVB | Rolke James | CEO, Dir | A - Grant | $0.9 | +532.8K | 933.5K | +133% | +$479.5K | |
| 2026-01-12 | 2026-01-08 | REVB | Chawla Lakhmir S | Dir | A - Grant | $0.9 | +42.0K | 57.7K | +268% | +$37.8K | |
| 2026-01-12 | 2026-01-08 | REVB | CARVER JENNIFER | Dir | A - Grant | $0.9 | +42.0K | 57.7K | +268% | +$37.8K | |
| 2025-10-31 | 2025-10-29 | REVB | Chawla Lakhmir S | Dir | A - Grant | $1.28 | +15.6K | 15.7K | +25,615% | +$20.0K | |
| 2025-10-31 | 2025-10-29 | REVB | ROPER JESS | Dir | A - Grant | $1.28 | +15.6K | 15.7K | +25,615% | +$20.0K | |
| 2025-10-31 | 2025-10-29 | REVB | CARVER JENNIFER | Dir | A - Grant | $1.28 | +15.6K | 15.7K | +24,802% | +$20.0K | |
| I | 2025-10-31 | 2025-10-29 | REVB | Zygmont Chester Stanley III | CFO | A - Grant | $1.28 | +390.6K | 395.6K | +7,764% | +$500.0K |
| 2025-10-31 | 2025-10-29 | REVB | Rolke James | CEO, Dir | A - Grant | $1.28 | +390.6K | 400.7K | +3,888% | +$500.0K | |
| I | 2025-02-13 | 2025-02-11 | REVB | TIDMARSH GEORGE F | Dir | A - Grant | $3.87 | +181 | 268 | +208% | +$700.47 |
| 2025-02-13 | 2025-02-11 | REVB | Chawla Lakhmir S | Dir | A - Grant | $3.87 | +181 | 181 | New | +$700.47 | |
| 2025-02-13 | 2025-02-11 | REVB | ROPER JESS | Dir | A - Grant | $3.87 | +181 | 183 | +9,050% | +$700.47 | |
| I | 2025-02-13 | 2025-02-11 | REVB | Zygmont Chester Stanley III | CFO | A - Grant | $3.87 | +15.0K | 15.1K | +53,743% | +$58.2K |
| 2025-02-13 | 2025-02-11 | REVB | Rolke James | CEO, Dir | A - Grant | $3.87 | +30.1K | 30.1K | +71,655% | +$116.5K | |
| 2025-02-13 | 2025-02-11 | REVB | CARVER JENNIFER | Dir | A - Grant | $3.87 | +181 | 187 | +3,017% | +$700.47 | |
| 2023-12-12 | 2023-12-08 | REVB | TIDMARSH GEORGE F | Dir | S - Sale | $0.52 | -27.8K | 0 | -100% | -$14.4K | |
| 2023-10-18 | 2023-10-16 | REVB | TIDMARSH GEORGE F | Dir | S - Sale | $0.65 | -1,845 | 27.8K | -6% | -$1,199 | |
| I | 2023-10-17 | 2023-10-16 | REVB | TIDMARSH GEORGE F | Dir | S - Sale | $0.66 | -11.0K | 42.1K | -21% | -$7,232 |
| I | 2023-10-02 | 2023-09-28 | REVB | TIDMARSH GEORGE F | Dir | S - Sale | $0.69 | -1,429 | 42.1K | -3% | -$986.01 |
| M | 2023-09-18 | 2023-09-14+ | REVB | TIDMARSH GEORGE F | Dir | S - Sale | $0.741 | -25.5K | 39.3K | -39% | -$18.9K |
| M | 2023-04-19 | 2023-04-17+ | REVB | TIDMARSH GEORGE F | Dir | P - Purchase | $1.16 | +51.5K | 39.8K | New | +$59.7K |
| 2022-02-28 | 2022-02-25 | REVB | TIDMARSH GEORGE F | Dir, 10% | P - Purchase | $1.60 | +20.0K | 467.2K | +4% | +$32.0K | |
| M | 2022-02-10 | 2022-02-08+ | REVB | TIDMARSH GEORGE F | Dir, 10% | P - Purchase | $2.55 | +31.0K | 447.2K | +7% | +$79.0K |
| A | 2022-02-09 | 2022-02-04 | REVB | TIDMARSH GEORGE F | Dir, 10% | P - Purchase | $2.45 | +2,000 | 416.2K | +0.5% | +$4,900 |
| MAI | 2022-02-09 | 2022-02-04+ | REVB | TIDMARSH GEORGE F | Dir, 10% | P - Purchase | $2.56 | +50.0K | 1.48M | +3% | +$128.1K |
| MI | 2022-02-08 | 2022-02-04+ | REVB | TIDMARSH GEORGE F | Dir, 10% | P - Purchase | $2.56 | +50.0K | 1.48M | +3% | +$128.1K |
| I | 2022-01-11 | 2022-01-10 | REVB | Feis Lawrence | 10% | J - Other | $10.20 | -732.0K | 0 | -100% | -$7.47M |
| MI | 2021-09-23 | 2021-09-21+ | REVB | GLAZER CAPITAL, LLC | 10% | S - Sale | $10.08 | -654.5K | 381.1K | -63% | -$6.60M |
Purchase Sale Sale after option exercise All abbreviations